NASDAQ:NH - NantHealth Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$3.07 -0.11 (-3.46 %)
(As of 07/23/2018 06:00 AM ET)
Previous Close$3.07
Today's Range$3.06 - $3.20
52-Week Range$2.60 - $5.26
Volume64,189 shs
Average Volume70,166 shs
Market Capitalization$333.38 million
P/E Ratio-2.74
Dividend YieldN/A
Beta0.23
NantHealth logoNantHealth, Inc., together with its subsidiaries, operates as an evidence-based personalized healthcare company in the United States and internationally. The company engages in converging science and technology through an integrated clinical platform to provide health information at the point of care. It develops NantHealth solution, an adaptive learning system, including molecular profiling solution, software, and hardware systems infrastructure that collects, indexes, analyzes, and interprets various molecular, clinical, operational, and financial data points derived from various sources to enhance decision-making. The company's products include GPS Cancer, a molecular profile that integrates whole genome sequencing of tumor and normal germline samples, whole transcriptome sequencing, and quantitative proteomics; GPS Cancer Report, a GPS cancer solution; GPS in rare diseases and chronic illnesses; and Eviti, a decision support solution. It also provides Web-based and mobile software solutions, such as Device Connectivity Suite, a device connectivity and near real-time biometric software and hardware suite; DeviceConX, a device data normalization software; HBox, an Internet of Medical Things and Internet of Things hardware hub; and VitalsConX, a tablet-optimized application. In addition, NantHealth, Inc. offers NaviNet Open, a payer-provider collaboration platform comprising plan central, eligibility and benefit, claims status inquiry, claims management, referral, authorization, document exchange, and AllPayer services; and cloud-based computing, storage, and transport infrastructure-as-a-service solutions. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was founded in 2010 and is headquartered in Culver City, California. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.

Receive NH News and Ratings via Email

Sign-up to receive the latest news and ratings for NH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Data processing & preparation
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:NH
CUSIPN/A
Phone310-883-1300

Debt

Debt-to-Equity Ratio1.15
Current Ratio1.90
Quick Ratio1.88

Price-To-Earnings

Trailing P/E Ratio-2.74
Forward P/E Ratio-5.12
P/E GrowthN/A

Sales & Book Value

Annual Sales$86.68 million
Price / Sales3.85
Cash FlowN/A
Price / CashN/A
Book Value$1.78 per share
Price / Book1.72

Profitability

EPS (Most Recent Fiscal Year)($1.12)
Net Income$-175,210,000.00
Net Margins-168.84%
Return on Equity-63.06%
Return on Assets-28.77%

Miscellaneous

Employees494
Outstanding Shares108,590,000
Market Cap$333.38

NantHealth (NASDAQ:NH) Frequently Asked Questions

What is NantHealth's stock symbol?

NantHealth trades on the NASDAQ under the ticker symbol "NH."

How were NantHealth's earnings last quarter?

NantHealth Inc (NASDAQ:NH) released its quarterly earnings results on Wednesday, May, 9th. The company reported ($0.12) earnings per share for the quarter, hitting the Zacks' consensus estimate of ($0.12). The company earned $22.26 million during the quarter, compared to analysts' expectations of $23.30 million. NantHealth had a negative return on equity of 63.06% and a negative net margin of 168.84%. View NantHealth's Earnings History.

What price target have analysts set for NH?

3 Wall Street analysts have issued 1-year price objectives for NantHealth's stock. Their forecasts range from $4.50 to $5.00. On average, they anticipate NantHealth's share price to reach $4.8333 in the next year. This suggests a possible upside of 57.4% from the stock's current price. View Analyst Ratings for NantHealth.

What is the consensus analysts' recommendation for NantHealth?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NantHealth in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Who are some of NantHealth's key competitors?

Who are NantHealth's key executives?

NantHealth's management team includes the folowing people:
  • Dr. Patrick Soon-Shiong FRCS (C), M.D., FACS, Founder, Chairman & CEO (Age 65)
  • Mr. Paul A. Holt, Chief Financial Officer (Age 52)
  • Mr. Ronald Allen Louks, COO & Director (Age 53)
  • Mr. Brandon Villery, VP, Gen. Counsel & Corp. Sec.
  • Mr. Charles Hunt, VP of Marketing, Communications & User Experience

When did NantHealth IPO?

(NH) raised $91 million in an IPO on Thursday, June 2nd 2016. The company issued 6,500,000 shares at a price of $12.50-$15.50 per share. Jefferies and Cowen and Company acted as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

Has NantHealth been receiving favorable news coverage?

News stories about NH stock have been trending somewhat positive recently, Accern Sentiment reports. The research firm identifies positive and negative media coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. NantHealth earned a news sentiment score of 0.15 on Accern's scale. They also gave media coverage about the company an impact score of 46.13 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

How do I buy shares of NantHealth?

Shares of NH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is NantHealth's stock price today?

One share of NH stock can currently be purchased for approximately $3.07.

How big of a company is NantHealth?

NantHealth has a market capitalization of $333.38 million and generates $86.68 million in revenue each year. The company earns $-175,210,000.00 in net income (profit) each year or ($1.12) on an earnings per share basis. NantHealth employs 494 workers across the globe.

How can I contact NantHealth?

NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The company can be reached via phone at 310-883-1300 or via email at [email protected]


MarketBeat Community Rating for NantHealth (NASDAQ NH)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  160 (Vote Outperform)
Underperform Votes:  136 (Vote Underperform)
Total Votes:  296
MarketBeat's community ratings are surveys of what our community members think about NantHealth and other stocks. Vote "Outperform" if you believe NH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/23/2018 by MarketBeat.com Staff

Featured Article: What are CEFs?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.